主动脉内球囊反搏在急性心肌梗死合并心源性休克患者冠状动脉介入术治疗中的应用
马晔， 马建芳， 李玫 - 中国综合临床, 2009 - cqvip.com
目的探讨主动脉内球囊反搏(IABP) 在急性心肌梗死(AMI) 合并心源性休克(CS)
患者冠状动脉介入(PCI) 治疗中的安全性和有效性. 方法将AMI 合并CS 患者分为单纯PCI …
患者冠状动脉介入(PCI) 治疗中的安全性和有效性. 方法将AMI 合并CS 患者分为单纯PCI …
Comparison of early and long-term results of percutaneous coronary interventions in patients with ST elevation myocardial infarction, complicated or not by …
A Lekston, G Slonka, M Gasior, D Pres… - Coronary Artery …, 2010 - journals.lww.com
Objectives Cardiogenic shock (CS) still remains one of the most important factors affecting
the mortality rate of patients with ST segment elevation myocardial infarction (STEMI) …
the mortality rate of patients with ST segment elevation myocardial infarction (STEMI) …
Relation of hemoglobin level to no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention
B Yaylak, B Altıntaş, KS Özcan, E Akdeniz… - … Cardiology/Postępy w …, 2018 - termedia.pl
The primary goal in the management of acute ST segment elevation myocardial infarction
(STEMI) is to open the occluded artery at an early stage. The development of no-reflow is …
(STEMI) is to open the occluded artery at an early stage. The development of no-reflow is …
Cardiogenic shock complicating myocardial infarction and outcome following percutaneous coronary intervention
KW Lee, MS Norell - Acute Cardiac Care, 2008 - Taylor & Francis
Cardiogenic shock is the commonest cause of death in acute myocardial infarction (AMI).
Although the syndrome of cardiogenic shock complicating AMI is common to all, the …
Although the syndrome of cardiogenic shock complicating AMI is common to all, the …
Intervencionismo en el contexto del infarto de miocardio. Conceptos actuales
E García - Revista española de cardiología, 2005 - Elsevier
La reperfusión mecánica (percutánea) en el contexto del infarto agudo de miocardio con
elevación del segmento ST ha demostrado ser la forma más eficaz para restaurar un flujo …
elevación del segmento ST ha demostrado ser la forma más eficaz para restaurar un flujo …
[HTML][HTML] Long-term predictive factors of major adverse cardiac events in patients with acute myocardial infarction complicated by cardiogenic shock
EH Bae, SY Lim, MH Jeong, HW Park… - The Korean Journal …, 2005 - ncbi.nlm.nih.gov
Background Cardiogenic shock (CS) after acute myocardial infarction (AMI) develops in 5~
10% of patients and it is associated with high mortality. The aim of this study is to assess the …
10% of patients and it is associated with high mortality. The aim of this study is to assess the …
[HTML][HTML] Predictive factors for successful weaning from percutaneous cardiopulmonary support in patients with cardiogenic shock complicating acute myocardial …
D Morisawa, Y Higuchi, K Iwakura, A Okamura… - Journal of …, 2012 - Elsevier
BACKGROUND AND PURPOSE: Percutaneous cardiopulmonary support (PCPS) is useful
in the rescue of patients who have experienced severe cardiogenic shock. We investigated …
in the rescue of patients who have experienced severe cardiogenic shock. We investigated …
[PDF][PDF] Original article Impact of the time to reperfusion on early outcomes in patients with acute myocardial infarction undergoing primary angioplasty
E Trzos, M Kurpesa, Z Bednarkiewicz… - Kardiologia Polska …, 2007 - journals.viamedica.pl
Background: The ACC/AHA guidelines for management of patients with ST-elevation
myocardial infarction (STEMI) have recommended primary PCI (pPCI) as the preferred …
myocardial infarction (STEMI) have recommended primary PCI (pPCI) as the preferred …
The evaluation and management of cardiogenic shock
PB Gogo Jr - Critical pathways in cardiology, 2006 - journals.lww.com
Cardiogenic shock (CS) continues to be the leading cause of death in patients who present
to the hospital with acute myocardial infarction (AMI). Mortality in patients with AMI …
to the hospital with acute myocardial infarction (AMI). Mortality in patients with AMI …
PCI 引起冠心病患者血清ox-Lp (a) 和β_2-GPI-ox-Lp (a) 水平升高
杨琛， 时永辉， 訾瑞峰， 牛冬梅， 汪俊军， 张春妮 - 标记免疫分析与临床, 2014 - cqvip.com
目的检测比较冠心病(coronary heart disease, CHD) 患者经皮冠状动脉介入治疗术(
percutaneous coronary intervention, PCI) 前, 后血清氧化脂蛋白(a)[ox-Lp (a)] 和β2-糖蛋白I …
percutaneous coronary intervention, PCI) 前, 后血清氧化脂蛋白(a)[ox-Lp (a)] 和β2-糖蛋白I …